nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—connective tissue—systemic scleroderma	0.0582	0.43	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—digestive system—systemic scleroderma	0.042	0.311	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—lung—systemic scleroderma	0.0351	0.259	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—HSPG2—systemic scleroderma	0.0289	0.297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.0247	0.254	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0185	0.0241	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—HSPG2—systemic scleroderma	0.0148	0.152	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Pentoxifylline—systemic scleroderma	0.0133	0.0173	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0122	0.016	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.0122	0.0158	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00966	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00954	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00898	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00868	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Leflunomide—systemic scleroderma	0.0084	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mometasone—systemic scleroderma	0.00834	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Leflunomide—systemic scleroderma	0.00828	0.0108	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mometasone—systemic scleroderma	0.00823	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mometasone—systemic scleroderma	0.00817	0.0106	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00801	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Mycophenolic acid—systemic scleroderma	0.0079	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pentoxifylline—systemic scleroderma	0.00788	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00774	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00751	0.00979	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mometasone—systemic scleroderma	0.00749	0.00976	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Captopril—systemic scleroderma	0.00732	0.00954	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Pentoxifylline—systemic scleroderma	0.00726	0.00946	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Captopril—systemic scleroderma	0.00723	0.00942	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Lisinopril—systemic scleroderma	0.00722	0.00941	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Captopril—systemic scleroderma	0.00717	0.00935	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Lisinopril—systemic scleroderma	0.00711	0.00927	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Pentoxifylline—systemic scleroderma	0.00698	0.0091	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Pentoxifylline—systemic scleroderma	0.00692	0.00902	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pentoxifylline—systemic scleroderma	0.00691	0.00901	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Pentoxifylline—systemic scleroderma	0.00688	0.00896	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Captopril—systemic scleroderma	0.0068	0.00887	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mometasone—systemic scleroderma	0.0068	0.00886	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Leflunomide—systemic scleroderma	0.00672	0.00876	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Captopril—systemic scleroderma	0.00658	0.00857	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pentoxifylline—systemic scleroderma	0.00652	0.0085	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Mometasone—systemic scleroderma	0.00648	0.00845	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00641	0.00836	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00632	0.00824	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00627	0.00817	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00623	0.00812	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Leflunomide—systemic scleroderma	0.00604	0.00787	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mometasone—systemic scleroderma	0.00602	0.00785	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mometasone—systemic scleroderma	0.00597	0.00778	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Captopril—systemic scleroderma	0.00597	0.00778	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mometasone—systemic scleroderma	0.00597	0.00778	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Leflunomide—systemic scleroderma	0.00596	0.00777	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00594	0.00774	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mometasone—systemic scleroderma	0.00593	0.00773	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00592	0.00771	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Leflunomide—systemic scleroderma	0.00591	0.0077	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00576	0.0075	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Azathioprine—systemic scleroderma	0.00574	0.00748	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Captopril—systemic scleroderma	0.00569	0.00742	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00569	0.00741	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00565	0.00736	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mycophenolic acid—systemic scleroderma	0.00564	0.00735	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mometasone—systemic scleroderma	0.00563	0.00733	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00561	0.00731	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Captopril—systemic scleroderma	0.0055	0.00717	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Leflunomide—systemic scleroderma	0.00542	0.00706	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00535	0.00697	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Captopril—systemic scleroderma	0.00529	0.00689	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Captopril—systemic scleroderma	0.00525	0.00684	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Captopril—systemic scleroderma	0.00524	0.00683	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Captopril—systemic scleroderma	0.00521	0.00679	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Lisinopril—systemic scleroderma	0.00519	0.00676	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00517	0.00674	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Lisinopril—systemic scleroderma	0.00512	0.00667	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00509	0.00663	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Lisinopril—systemic scleroderma	0.00508	0.00662	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00506	0.0066	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Azathioprine—systemic scleroderma	0.00497	0.00647	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Captopril—systemic scleroderma	0.00494	0.00644	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00493	0.00642	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Leflunomide—systemic scleroderma	0.00492	0.00641	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00482	0.00628	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Azathioprine—systemic scleroderma	0.0048	0.00626	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00469	0.00612	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Leflunomide—systemic scleroderma	0.00469	0.00611	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Lisinopril—systemic scleroderma	0.00466	0.00607	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Azathioprine—systemic scleroderma	0.00462	0.00602	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Azathioprine—systemic scleroderma	0.00458	0.00597	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Azathioprine—systemic scleroderma	0.00457	0.00596	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Azathioprine—systemic scleroderma	0.00455	0.00593	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00454	0.00592	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Leflunomide—systemic scleroderma	0.00453	0.00591	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00449	0.00585	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00448	0.00583	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00446	0.00581	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Leflunomide—systemic scleroderma	0.00436	0.00568	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Mycophenolic acid—systemic scleroderma	0.00433	0.00564	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Leflunomide—systemic scleroderma	0.00432	0.00563	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Leflunomide—systemic scleroderma	0.00432	0.00563	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Azathioprine—systemic scleroderma	0.00431	0.00562	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Leflunomide—systemic scleroderma	0.0043	0.0056	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Prednisone—systemic scleroderma	0.00429	0.00559	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Lisinopril—systemic scleroderma	0.00423	0.00551	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00422	0.0055	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00416	0.00542	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mycophenolic acid—systemic scleroderma	0.00412	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00412	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mycophenolic acid—systemic scleroderma	0.0041	0.00534	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00408	0.00532	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Leflunomide—systemic scleroderma	0.00407	0.00531	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Lisinopril—systemic scleroderma	0.00403	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Lisinopril—systemic scleroderma	0.0039	0.00508	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mycophenolic acid—systemic scleroderma	0.00389	0.00506	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Lisinopril—systemic scleroderma	0.00375	0.00488	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Lisinopril—systemic scleroderma	0.00371	0.00484	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Lisinopril—systemic scleroderma	0.00371	0.00484	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0037	0.00483	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Lisinopril—systemic scleroderma	0.00369	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Methotrexate—systemic scleroderma	0.00358	0.00467	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00353	0.0046	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00353	0.0363	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Lisinopril—systemic scleroderma	0.0035	0.00456	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Prednisone—systemic scleroderma	0.00343	0.00447	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00341	0.00445	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00328	0.00428	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00323	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Prednisone—systemic scleroderma	0.00308	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00307	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Prednisone—systemic scleroderma	0.00304	0.00396	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Prednisone—systemic scleroderma	0.00302	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Methotrexate—systemic scleroderma	0.00287	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00286	0.00373	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Prednisone—systemic scleroderma	0.00277	0.0036	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00268	0.0275	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Methotrexate—systemic scleroderma	0.00257	0.00335	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SMAD7—systemic scleroderma	0.00257	0.0264	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Methotrexate—systemic scleroderma	0.00254	0.00331	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00252	0.00329	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methotrexate—systemic scleroderma	0.00252	0.00329	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Prednisone—systemic scleroderma	0.00251	0.00327	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Prednisone—systemic scleroderma	0.00239	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00239	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFBI—systemic scleroderma	0.00235	0.0242	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Prednisone—systemic scleroderma	0.00231	0.00302	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Methotrexate—systemic scleroderma	0.00231	0.00301	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Prednisone—systemic scleroderma	0.00222	0.0029	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Prednisone—systemic scleroderma	0.00221	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisone—systemic scleroderma	0.0022	0.00287	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Prednisone—systemic scleroderma	0.00219	0.00286	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Methotrexate—systemic scleroderma	0.0021	0.00273	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Prednisone—systemic scleroderma	0.00208	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methotrexate—systemic scleroderma	0.002	0.00261	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Methotrexate—systemic scleroderma	0.00193	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPG2—systemic scleroderma	0.00188	0.0193	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Methotrexate—systemic scleroderma	0.00186	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Methotrexate—systemic scleroderma	0.00184	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methotrexate—systemic scleroderma	0.00184	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methotrexate—systemic scleroderma	0.00183	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CSK—systemic scleroderma	0.00181	0.0186	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMAD7—systemic scleroderma	0.0018	0.0185	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Methotrexate—systemic scleroderma	0.00174	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD247—systemic scleroderma	0.0017	0.0175	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSPG2—systemic scleroderma	0.00157	0.0162	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RHOB—systemic scleroderma	0.00139	0.0143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSPG2—systemic scleroderma	0.00131	0.0135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CSK—systemic scleroderma	0.00127	0.013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CTGF—systemic scleroderma	0.00119	0.0122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDN1—systemic scleroderma	0.000712	0.00731	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—systemic scleroderma	0.000619	0.00636	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—systemic scleroderma	0.000519	0.00533	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—systemic scleroderma	0.000487	0.005	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—systemic scleroderma	0.000434	0.00446	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—systemic scleroderma	0.000409	0.00421	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—systemic scleroderma	0.000348	0.00357	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—systemic scleroderma	0.000287	0.00295	CbGpPWpGaD
